Completed EARLY_PHASE1 INTERVENTIONAL 3-arm NCT01582113

Cognizin Citicoline Dosing in a Healthy Adolescent Male Population

Sponsor: Deborah Yurgelun-Todd

Interventions Citicoline Microcrystalline Cellulose

Updated 8 times since 2017 Last updated: Feb 14, 2019 Started: Jun 30, 2012 Primary completion: May 24, 2017 Completion: May 24, 2017

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

This EARLY_PHASE1 trial investigates Neurocognitive Improvement and is currently completed. Deborah Yurgelun-Todd leads this study, which shows 8 recorded versions since 2012 — indicating limited longitudinal coverage. The change history captured here reflects the iterative nature of clinical trial conduct.

Status Flow

Change History

8 versions recorded

Sep 2024 — Present [monthly]

Completed EARLY_PHASE1
Jul 2024 — Sep 2024 [monthly]

Completed EARLY_PHASE1
Jan 2021 — Jul 2024 [monthly]

Completed EARLY_PHASE1
Mar 2019 — Jan 2021 [monthly]

Completed EARLY_PHASE1

Phase: NA → EARLY_PHASE1
Jun 2018 — Mar 2019 [monthly]

Completed NA

▶ Show 3 earlier versions

Jul 2017 — Jun 2018 [monthly]

Completed NA

Status: Active Not Recruiting → Completed
Feb 2017 — Jul 2017 [monthly]

Active Not Recruiting NA
Jan 2017 — Feb 2017 [monthly]

Active Not Recruiting NA

First recorded

Jun 2012

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Deborah Yurgelun-Todd

Data source: University of Utah

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Salt Lake City, United States